|
JPS5186117A
(en)
|
1975-01-27 |
1976-07-28 |
Tanabe Seiyaku Co |
Johoseibiryushiseizainoseiho |
|
US3998795A
(en)
*
|
1975-06-23 |
1976-12-21 |
American Home Products Corporation |
(Acyl-D-α-amino acid-gly-gly-tyr-ala)1 -somatostatin
|
|
GB1575343A
(en)
|
1977-05-10 |
1980-09-17 |
Ici Ltd |
Method for preparing liposome compositions containing biologically active compounds
|
|
US4529561A
(en)
|
1978-03-24 |
1985-07-16 |
The Regents Of The University Of California |
Method for producing liposomes in selected size range
|
|
US4801580A
(en)
*
|
1978-11-14 |
1989-01-31 |
Fujisawa Pharmaceutical Company, Ltd. |
Peptide, process for preparation thereof and use thereof
|
|
GB2046092B
(en)
|
1979-03-05 |
1983-11-02 |
Toyama Chemical Co Ltd |
Pharmaceutical composition containing a lysophospholid and a phospholipid
|
|
US5019383A
(en)
*
|
1981-01-09 |
1991-05-28 |
New York Blood Center, Inc. |
Fatty acid carriers for synthetic peptides
|
|
US4452747A
(en)
|
1982-03-22 |
1984-06-05 |
Klaus Gersonde |
Method of and arrangement for producing lipid vesicles
|
|
DE3480392D1
(en)
*
|
1983-04-29 |
1989-12-14 |
Ciba Geigy Ag |
Imidazolides and their use as curing agents for polyepoxides
|
|
US4725442A
(en)
|
1983-06-17 |
1988-02-16 |
Haynes Duncan H |
Microdroplets of water-insoluble drugs and injectable formulations containing same
|
|
US5008050A
(en)
|
1984-06-20 |
1991-04-16 |
The Liposome Company, Inc. |
Extrusion technique for producing unilamellar vesicles
|
|
US4921706A
(en)
|
1984-11-20 |
1990-05-01 |
Massachusetts Institute Of Technology |
Unilamellar lipid vesicles and method for their formation
|
|
US5837249A
(en)
*
|
1985-04-19 |
1998-11-17 |
The Wistar Institute |
Method for generating an immunogenic T cell response protective against a virus
|
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
|
US7138486B2
(en)
|
1986-05-05 |
2006-11-21 |
The General Hospital Corporation |
Insulinotropic hormone derivatives and uses thereof
|
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US6849708B1
(en)
|
1986-05-05 |
2005-02-01 |
The General Hospital Corporation |
Insulinotropic hormone and uses thereof
|
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5527524A
(en)
|
1986-08-18 |
1996-06-18 |
The Dow Chemical Company |
Dense star polymer conjugates
|
|
US4920016A
(en)
|
1986-12-24 |
1990-04-24 |
Linear Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5009956A
(en)
|
1987-02-24 |
1991-04-23 |
Univ Minnesota |
Phospholipase A2-resistant liposomes
|
|
US4857311A
(en)
|
1987-07-31 |
1989-08-15 |
Massachusetts Institute Of Technology |
Polyanhydrides with improved hydrolytic degradation properties
|
|
US5681543A
(en)
|
1988-02-29 |
1997-10-28 |
Shering Aktiengesellschaft |
Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI
|
|
US4927637A
(en)
|
1989-01-17 |
1990-05-22 |
Liposome Technology, Inc. |
Liposome extrusion method
|
|
US5116603A
(en)
|
1989-01-31 |
1992-05-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Oral antifungal preventative, and method of use
|
|
US4944948A
(en)
|
1989-02-24 |
1990-07-31 |
Liposome Technology, Inc. |
EGF/Liposome gel composition and method
|
|
US5744166A
(en)
|
1989-02-25 |
1998-04-28 |
Danbiosyst Uk Limited |
Drug delivery compositions
|
|
US5554388A
(en)
|
1989-02-25 |
1996-09-10 |
Danbiosyst Uk Limited |
Systemic drug delivery compositions comprising a polycationi substance
|
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
|
AU3124793A
(en)
|
1991-10-29 |
1993-06-07 |
Clover Consolidated, Limited |
Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
|
|
US5770563A
(en)
|
1991-12-06 |
1998-06-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Heparin- and sulfatide binding peptides from the type I repeats of human thrombospondin and conjugates thereof
|
|
NL9200481A
(nl)
*
|
1992-03-13 |
1993-10-01 |
Univ Groningen |
Farmaceutisch preparaat met plaatsgerichte afgifte.
|
|
US6113946A
(en)
|
1992-04-03 |
2000-09-05 |
The Regents Of The University Of California |
Self-assembling polynucleotide delivery system comprising dendrimer polycations
|
|
ES2221920T3
(es)
|
1992-04-03 |
2005-01-16 |
The Regents Of The University Of California |
Sistema de liberacion de polinucleotidos de autoensamblaje que comprende un peptido cationico anfipatico.
|
|
WO1994005203A1
(en)
|
1992-09-04 |
1994-03-17 |
The General Hospital Corporation |
Biocompatible polymers containing diagnostic or therapeutic moieties
|
|
US5871710A
(en)
|
1992-09-04 |
1999-02-16 |
The General Hospital Corporation |
Graft co-polymer adducts of platinum (II) compounds
|
|
US7319000B1
(en)
*
|
1992-09-16 |
2008-01-15 |
Board Of Regents, The University Of Texas System |
Compositions and methods for eliciting immune or anti-infective responses
|
|
US5395619A
(en)
|
1993-03-03 |
1995-03-07 |
Liposome Technology, Inc. |
Lipid-polymer conjugates and liposomes
|
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
|
US5605672A
(en)
|
1993-06-09 |
1997-02-25 |
The General Hospital Corporation |
Blood pool imaging composition and method of its use
|
|
DK0710243T3
(da)
|
1993-06-29 |
2000-10-16 |
Ferring Bv |
Syntese af cykliske peptider
|
|
US5763585A
(en)
|
1993-10-13 |
1998-06-09 |
Anergen, Inc. |
Method of making MHC-peptide complexes using metal chelate affinity chromatography
|
|
MX9504664A
(es)
|
1994-03-07 |
1997-05-31 |
Dow Chemical Co |
Conjugados de dendrimeros bioactivos y/o dirigidos.
|
|
CA2190121A1
(en)
|
1994-03-15 |
1995-09-21 |
Edith Mathiowitz |
Polymeric gene delivery system
|
|
US5466467A
(en)
|
1994-03-30 |
1995-11-14 |
The United States Of America As Represented By The Secretary Of The Navy |
Liposomes containing polymerized lipids for non-covalent immobilization of proteins and enzymes
|
|
GB9409496D0
(en)
|
1994-05-12 |
1994-06-29 |
London Health Ass |
Method for improving glycaemic control in diabetes
|
|
US20010006943A1
(en)
|
1994-12-23 |
2001-07-05 |
Ejvind Jensen |
Protracted GLP-1 compositions
|
|
US5834428A
(en)
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
|
US6096871A
(en)
*
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
|
US5855610A
(en)
|
1995-05-19 |
1999-01-05 |
Children's Medical Center Corporation |
Engineering of strong, pliable tissues
|
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
|
US5891418A
(en)
|
1995-06-07 |
1999-04-06 |
Rhomed Incorporated |
Peptide-metal ion pharmaceutical constructs and applications
|
|
EP0830381A4
(en)
|
1995-06-09 |
2000-11-22 |
William N Drohan |
CHITINE HYDROGELS, PRODUCTION METHOD AND USE
|
|
US5942253A
(en)
|
1995-10-12 |
1999-08-24 |
Immunex Corporation |
Prolonged release of GM-CSF
|
|
AU730969B2
(en)
|
1995-10-19 |
2001-03-22 |
University Of Washington |
Discrete-length polyethylene glycols
|
|
ES2448467T3
(es)
|
1996-03-12 |
2014-03-14 |
Pg-Txl Company, L.P. |
Profármacos solubles en agua
|
|
US6576636B2
(en)
|
1996-05-22 |
2003-06-10 |
Protarga, Inc. |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates
|
|
US6254854B1
(en)
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
|
WO1998008874A1
(en)
*
|
1996-08-27 |
1998-03-05 |
Chiron Corporation |
Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
|
|
US6006753A
(en)
|
1996-08-30 |
1999-12-28 |
Eli Lilly And Company |
Use of GLP-1 or analogs to abolish catabolic changes after surgery
|
|
US6277819B1
(en)
|
1996-08-30 |
2001-08-21 |
Eli Lilly And Company |
Use of GLP-1 or analogs in treatment of myocardial infarction
|
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
UA65549C2
(uk)
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
|
|
JPH10158195A
(ja)
|
1996-11-28 |
1998-06-16 |
Res Inst For Prod Dev |
配位結合を利用した薬物−高分子複合体製剤の調製方法
|
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
|
EP0981625A2
(en)
*
|
1997-05-06 |
2000-03-01 |
Human Genome Sciences, Inc. |
$i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES
|
|
WO1999003488A2
(en)
*
|
1997-07-15 |
1999-01-28 |
Magainin Pharmaceuticals Inc. |
Biologically active peptides with reduced toxicity in animals and a method for preparing same
|
|
CN1271277A
(zh)
|
1997-07-18 |
2000-10-25 |
因菲米德有限公司 |
用于生物活性物质控释的生物可降解的大分子的单体
|
|
US6468532B1
(en)
|
1998-01-22 |
2002-10-22 |
Genentech, Inc. |
Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates
|
|
US6703359B1
(en)
|
1998-02-13 |
2004-03-09 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and GLP-1
|
|
WO1999042091A2
(en)
|
1998-02-19 |
1999-08-26 |
Massachusetts Institute Of Technology |
Use of polycations as endosomolytic agents
|
|
AU3247799A
(en)
*
|
1998-02-27 |
1999-09-15 |
Novo Nordisk A/S |
Glp-1 derivatives of glp-1 and exendin with protracted profile of action
|
|
US6998387B1
(en)
|
1998-03-19 |
2006-02-14 |
Amylin Pharmaceuticals, Inc. |
Human appetite control by glucagon-like peptide receptor binding compounds
|
|
ATE411049T1
(de)
|
1998-05-20 |
2008-10-15 |
Expression Genetics Inc |
Laktose oder galaktose-polyethylen glykol- gepfropfte poly-l-lysin als genträger
|
|
GB9811059D0
(en)
|
1998-05-23 |
1998-07-22 |
Univ Strathclyde |
Polyamino acid vesicles
|
|
US6509323B1
(en)
|
1998-07-01 |
2003-01-21 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
|
US7056734B1
(en)
|
1998-08-10 |
2006-06-06 |
The United States Of America As Represented By The Department Of Health And Human Services, Nih |
Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof
|
|
US6162462A
(en)
|
1998-08-12 |
2000-12-19 |
New York University |
Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient
|
|
IL125908A
(en)
*
|
1998-08-24 |
2005-05-17 |
Nst Neurosurvival Technologies |
Peptides and pharmaceutical compositions comprising same
|
|
US6284725B1
(en)
|
1998-10-08 |
2001-09-04 |
Bionebraska, Inc. |
Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
|
|
CA2358463A1
(en)
|
1999-01-08 |
2000-07-13 |
Virginia Commonwealth University |
Polymeric delivery agents and delivery agent compounds
|
|
US6365173B1
(en)
|
1999-01-14 |
2002-04-02 |
Efrat Biopolymers Ltd. |
Stereocomplex polymeric carriers for drug delivery
|
|
WO2000047236A1
(en)
|
1999-02-12 |
2000-08-17 |
Biostream, Inc. |
Matrices for drug delivery and methods for making and using the same
|
|
EP1190252B1
(en)
|
1999-04-28 |
2008-12-31 |
Eidgenössische Technische Hochschule Zürich |
Polyionic coatings in analytic and sensor devices
|
|
ATE252601T1
(de)
*
|
1999-05-17 |
2003-11-15 |
Conjuchem Inc |
Lang wirkende insulinotrope peptide
|
|
US6232366B1
(en)
|
1999-06-09 |
2001-05-15 |
3M Innovative Properties Company |
Pressure sensitive conductive adhesive having hot-melt properties and biomedical electrodes using same
|
|
WO2001028569A1
(en)
|
1999-10-15 |
2001-04-26 |
Canji, Inc. |
Targeted vectors
|
|
US6569832B1
(en)
|
1999-11-12 |
2003-05-27 |
Novo Nordisk A/S |
Inhibition of beta cell degeneration
|
|
US7060291B1
(en)
|
1999-11-24 |
2006-06-13 |
Transave, Inc. |
Modular targeted liposomal delivery system
|
|
US6593308B2
(en)
|
1999-12-03 |
2003-07-15 |
The Regents Of The University Of California |
Targeted drug delivery with a hyaluronan ligand
|
|
EP1267912A2
(en)
|
2000-03-14 |
2003-01-02 |
Burkhard Göke |
Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility
|
|
US6998137B2
(en)
|
2000-04-07 |
2006-02-14 |
Macromed, Inc. |
Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
|
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
|
CN103356996A
(zh)
|
2000-05-19 |
2013-10-23 |
埃米林药品公司 |
Glp-1用于制备治疗急性冠脉综合征的药物的用途
|
|
US6338859B1
(en)
|
2000-06-29 |
2002-01-15 |
Labopharm Inc. |
Polymeric micelle compositions
|
|
US20050089970A1
(en)
|
2000-07-12 |
2005-04-28 |
Bradburne James A. |
Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
|
|
AU2001284665B2
(en)
|
2000-07-21 |
2006-06-08 |
Revance Therapeutics, Inc. |
Multi-component Biological Transport Systems
|
|
US20040092432A1
(en)
|
2000-08-24 |
2004-05-13 |
Thomas Jefferson University |
Peptide compositions with effects on cerebral health
|
|
AU2001273388B2
(en)
|
2000-09-08 |
2005-01-13 |
Gryphon Therapeutics, Inc. |
"Pseudo"-native chemical ligation
|
|
EP1188443A1
(en)
|
2000-09-15 |
2002-03-20 |
Ferring BV |
Improved protocol for paracentesis
|
|
US6521736B2
(en)
|
2000-09-15 |
2003-02-18 |
University Of Massachusetts |
Amphiphilic polymeric materials
|
|
DE60142351D1
(de)
|
2000-10-20 |
2010-07-22 |
Amylin Pharmaceuticals Inc |
Behandlung von hypoaktivem myokard und diabetischer herzmyopathie mit einem glp-1 peptid
|
|
EP1215501A1
(en)
|
2000-11-30 |
2002-06-19 |
Molecular Devices Corporation |
Use of a poly(amino-acid)-metal ion complex to link a label to a species of interest
|
|
EP1351984A2
(en)
|
2000-12-13 |
2003-10-15 |
Eli Lilly And Company |
Amidated glucagon-like peptide-1
|
|
MXPA03005135A
(es)
|
2000-12-13 |
2003-12-04 |
Lilly Co Eli |
Regimen de tratamiento cronico usando peptidos insulinotropicos similares al glucagon.
|
|
DE60229352D1
(de)
|
2001-01-12 |
2008-11-27 |
Waratah Pharmaceuticals Inc |
Zusammensetzungen, welche gastrin/cck-rezeptorligande und egf-rezeptorligande enthalten, zur induzierung der neogenese von inselzellen
|
|
DE60226702D1
(de)
*
|
2001-02-16 |
2008-07-03 |
Conjuchem Biotechnologies Inc |
Lang wirkendes glucagon-ähnliches peptid-2 für die behandlung von gastrointestinalen krankheiten und störungen
|
|
US20050153913A1
(en)
|
2001-04-10 |
2005-07-14 |
Kosak Kenneth M. |
Nucleic acid carrier compositions and methods for their synthesis
|
|
EP1542712A2
(en)
|
2001-06-01 |
2005-06-22 |
Eli Lilly And Company |
Glp-1 formulations with protracted time action
|
|
ATE382057T1
(de)
|
2001-06-28 |
2008-01-15 |
Novo Nordisk As |
Stabile formulierung von modifiziertem glp-1
|
|
US6586524B2
(en)
|
2001-07-19 |
2003-07-01 |
Expression Genetics, Inc. |
Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier
|
|
JP4227894B2
(ja)
|
2001-08-23 |
2009-02-18 |
イーライ リリー アンド カンパニー |
グルカゴン様ペプチド１アナログ
|
|
US7678769B2
(en)
*
|
2001-09-14 |
2010-03-16 |
Compugen, Ltd. |
Hepatocyte growth factor receptor splice variants and methods of using same
|
|
BR0212620A
(pt)
|
2001-10-01 |
2005-09-20 |
Lilly Co Eli |
Métodos de tratamento de pacientes criticamente doentes sofrendo de angústia respiratória, e de pacientes criticamente doente possuindo uma condição que acarreta a angústia respiratória, e, uso de um composto de glp-1
|
|
US7041646B2
(en)
|
2001-10-05 |
2006-05-09 |
Bayer Pharmaceuticals Corporation |
Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists
|
|
WO2003040399A2
(en)
|
2001-11-02 |
2003-05-15 |
Intradigm Corporation |
Therapeutic methods for nucleic acid delivery vehicles
|
|
US20050014681A1
(en)
|
2001-11-26 |
2005-01-20 |
Yoshiharu Minamitake |
Medicinal compositions for nasal absorption
|
|
US20030113270A1
(en)
*
|
2001-12-14 |
2003-06-19 |
Clark Abbot F. |
Vasoactive intestinal peptides for glaucomatous retinopathy
|
|
US7261875B2
(en)
|
2001-12-21 |
2007-08-28 |
Board Of Regents, The University Of Texas System |
Dendritic poly (amino acid) carriers and methods of use
|
|
WO2003066068A1
(en)
|
2002-02-01 |
2003-08-14 |
Intradigm Corporation |
Hpma-polyamine conjugates and uses therefore
|
|
US7371719B2
(en)
*
|
2002-02-15 |
2008-05-13 |
Northwestern University |
Self-assembly of peptide-amphiphile nanofibers under physiological conditions
|
|
NZ534125A
(en)
|
2002-02-20 |
2006-11-30 |
Emisphere Tech Inc |
A formulation comprising a GLP-1 compound and a delivery agent
|
|
US7635463B2
(en)
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
|
DE60335608D1
(de)
|
2002-02-27 |
2011-02-17 |
Pharmain Corp |
Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
|
|
EP1525219B1
(en)
|
2002-07-04 |
2009-05-27 |
Zealand Pharma A/S |
Glp-1 and methods for treating diabetes
|
|
US7148342B2
(en)
|
2002-07-24 |
2006-12-12 |
The Trustees Of The University Of Pennyslvania |
Compositions and methods for sirna inhibition of angiogenesis
|
|
CA2495172A1
(en)
|
2002-08-13 |
2004-02-19 |
Medtronic, Inc. |
Active agent delivery systems, medical devices, and methods
|
|
CA2497794A1
(en)
|
2002-09-06 |
2004-03-18 |
Bayer Pharmaceuticals Corporation |
Modified glp-1 receptor agonists and their pharmacological methods of use
|
|
US7790681B2
(en)
|
2002-12-17 |
2010-09-07 |
Amylin Pharmaceuticals, Inc. |
Treatment of cardiac arrhythmias with GLP-1 receptor ligands
|
|
US20040209803A1
(en)
|
2002-12-19 |
2004-10-21 |
Alain Baron |
Compositions for the treatment and prevention of nephropathy
|
|
CN1767815A
(zh)
|
2003-03-31 |
2006-05-03 |
阿尔萨公司 |
非水单相载体和使用这类载体的制剂
|
|
US7259234B2
(en)
*
|
2003-05-15 |
2007-08-21 |
Trustees Of Tufts College |
Stable analogs of peptide and polypeptide therapeutics
|
|
EP1631308B1
(en)
|
2003-05-30 |
2013-07-31 |
Amylin Pharmaceuticals, LLC |
Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins
|
|
KR101308912B1
(ko)
|
2003-06-03 |
2013-09-23 |
노보 노르디스크 에이/에스 |
안정화된 약학적 펩티드 조성물
|
|
ATE529126T1
(de)
|
2003-06-03 |
2011-11-15 |
Novo Nordisk As |
Stabilisierte pharmazeutische peptid zusammensetzungen
|
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
|
DK1641823T3
(da)
|
2003-06-12 |
2011-12-12 |
Lilly Co Eli |
GLP-1-analog fusionsproteiner
|
|
US20080026995A1
(en)
*
|
2003-07-25 |
2008-01-31 |
Ac Immune Sa |
Therapeutic vaccine targeted against p-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
|
|
US20060247167A1
(en)
|
2003-09-01 |
2006-11-02 |
Novo Nordisk A/S |
Stable formulations of peptides
|
|
JP2007514752A
(ja)
|
2003-12-16 |
2007-06-07 |
ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス |
Ｇｌｐ−１医薬組成物
|
|
US20060286129A1
(en)
|
2003-12-19 |
2006-12-21 |
Emisphere Technologies, Inc. |
Oral GLP-1 formulations
|
|
WO2005084180A2
(en)
|
2003-12-19 |
2005-09-15 |
University Of Cincinnati |
Polyamides and polyamide complexes for delivery of oligonucleotide decoys
|
|
US20050143303A1
(en)
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
|
US20060074025A1
(en)
|
2003-12-26 |
2006-04-06 |
Nastech Pharmaceutical Company Inc. |
Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
|
|
GB2429207A
(en)
*
|
2004-02-02 |
2007-02-21 |
Ambrx Inc |
Modified human interferon polypeptides and their uses
|
|
CA2555335A1
(en)
|
2004-02-05 |
2005-08-25 |
Intradigm Corporation |
Rnai therapeutics for treatment of eye neovascularization diseases
|
|
KR101284710B1
(ko)
|
2004-03-03 |
2013-07-23 |
레반스 테라퓨틱스, 아이엔씨. |
국소 진단제 및 치료제의 수송을 위한 조성물 및 방법
|
|
FR2867679B1
(fr)
|
2004-03-17 |
2008-08-22 |
Oreal |
Composition cosmetiques comprenant des polyamines modifiees et utilisations desdites compositions.
|
|
MXPA06012207A
(es)
|
2004-04-20 |
2007-02-13 |
Dendritic Nanotechnologies Inc |
Polimeros dendriticos con amplificacion mejorada y funcionalidad interior.
|
|
US7985424B2
(en)
|
2004-04-20 |
2011-07-26 |
Dendritic Nanotechnologies Inc. |
Dendritic polymers with enhanced amplification and interior functionality
|
|
WO2005112977A2
(en)
|
2004-04-23 |
2005-12-01 |
Pharmain, Ltd. |
Compositions for treatment with glucagon-like peptide, and methods of making and using the same
|
|
US20060035815A1
(en)
|
2004-05-04 |
2006-02-16 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical compositions for delivery of ribonucleic acid to a cell
|
|
US7534449B2
(en)
|
2004-07-01 |
2009-05-19 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
WO2006014425A1
(en)
|
2004-07-02 |
2006-02-09 |
Biovalve Technologies, Inc. |
Methods and devices for delivering glp-1 and uses thereof
|
|
WO2006014673A2
(en)
|
2004-07-19 |
2006-02-09 |
Nobex Corporation |
Insulin-oligomer conjugates, formulations and uses thereof
|
|
US20060040879A1
(en)
|
2004-08-21 |
2006-02-23 |
Kosak Kenneth M |
Chloroquine coupled nucleic acids and methods for their synthesis
|
|
CA2584095A1
(en)
|
2004-10-08 |
2006-04-20 |
Forbes Medi-Tech (Research) Inc. |
Vasoactive intestinal polypeptide pharmaceuticals
|
|
DE602005009738D1
(de)
|
2004-12-07 |
2008-10-23 |
Applied Nanosystems Bv |
Verfahren zur herstellung und sekretion modifizierter peptide
|
|
EP1836314B1
(en)
*
|
2004-12-22 |
2012-01-25 |
Ambrx, Inc. |
Modified human growth hormone
|
|
US20060233857A1
(en)
|
2005-04-14 |
2006-10-19 |
Amsden Brian G |
Degradable elastomeric network
|
|
WO2007024899A2
(en)
|
2005-08-23 |
2007-03-01 |
The General Hospital Corporation |
Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes
|
|
US20100041612A1
(en)
|
2005-09-08 |
2010-02-18 |
Martin Beinborn |
Fragments of the Glucagon-Like Peptide-1 and Uses Thereof
|
|
HUE031341T2
(hu)
|
2005-10-25 |
2017-07-28 |
Starpharma Pty Ltd |
Ellenõrzött sztöchiometriájú makromolekuláris vegyületek
|
|
PT1965823T
(pt)
|
2005-11-04 |
2016-08-18 |
Glaxosmithkline Llc |
Métodos para administração de agentes hipoglicémicos
|
|
JP2009520040A
(ja)
*
|
2005-12-19 |
2009-05-21 |
ファーマイン コーポレーション |
治療薬の送達のための疎水性コアの担体組成物、及び同担体組成物の作製法及び使用法
|
|
EP1981512B1
(en)
|
2006-01-20 |
2022-11-02 |
Starpharma Pty Limited |
Modified macromolecule
|
|
US20070225213A1
(en)
|
2006-03-23 |
2007-09-27 |
Kosak Matthew K |
Nucleic acid carriers for delivery of therapeutic agents
|
|
US8748567B2
(en)
|
2006-05-22 |
2014-06-10 |
Children's Medical Center Corporation |
Method for delivery across the blood brain barrier
|
|
US20080312174A1
(en)
|
2007-06-05 |
2008-12-18 |
Nitto Denko Corporation |
Water soluble crosslinked polymers
|
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
|
US8563527B2
(en)
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
|
WO2009065077A1
(en)
|
2007-11-16 |
2009-05-22 |
Pharmain Corporation |
Cationic-core carrier compositions for delivery of therapeutic agents, methods of making and using the same
|
|
US20090176892A1
(en)
|
2008-01-09 |
2009-07-09 |
Pharmain Corporation |
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|